Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
06/2010
06/01/2010US7728201 Soybean cultivar 7614385
06/01/2010US7728200 Soybean cultivar 7925118
06/01/2010US7728199 Soybean cultivar 7821295
06/01/2010US7728198 Soybean cultivar 7811336
06/01/2010US7728197 Soybean cultivar S07-03KG212421
06/01/2010US7728196 Soybean cultivar 6419156
06/01/2010US7728195 Canola cultivar DN040856
06/01/2010US7728194 Transgenic plants for use in enhanced food production in farming; mitochondrial gene transfer; increased storage stability
06/01/2010US7728193 Phytochrome-interacting protein and a use thereof
06/01/2010US7728192 Process for converting storage reserves of dicotyledonous seeds into compositions comprising one or more gene products
06/01/2010US7728191 Expession vector comprising nucleotide sequences which code and enhance prolamin polypeptide transcription and RNA interfereing sequence which decrease expression of preferential storage proteins in seeds
06/01/2010US7728190 Geneticallyengineered host cell for use as bioreactor in production of fungicidal proteins; disease resistant plants; storage stability; biologial pest control
06/01/2010US7728189 Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
06/01/2010US7728122 RTBV plant promoter and process thereof
06/01/2010US7728121 Nucleotide sequences coding portion of viral early gene; generating immunoglobulin for detecting viral infection
06/01/2010US7728118 Expression vector comprising modified luciferase for use as gene transfer and report agent in heterologous gene expression
06/01/2010US7728111 Anti-p55 TNF receptor antibody
06/01/2010US7728109 Antagonistic anti-hTNFSF13b human antibodies
06/01/2010US7728108 PRO1550 polypeptides
06/01/2010US7727970 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents targeted to Hepatitis C virus
06/01/2010US7727969 Controlled release nanoparticle having bound oligonucleotide for targeted delivery
06/01/2010US7727952 Methods for treating spinal and bulbar muscular atrophy using LHRH analogs
06/01/2010US7727950 Methods and reagents for assaying protein kinase activity
06/01/2010US7727762 Using mammalian pluripotent stem cells to generate cardiomyocytes for use in treatment of heart disease
06/01/2010US7727756 Modified hydrolase comprising ion binding site with enhanced storage stability and improved performance in washing and cleaning; detergents; biodegradation
06/01/2010US7727754 Nucleotide sequences coding cellulase for use in textile treatment, cleaning products and production of ethanol
06/01/2010US7727753 Plant dihydroorotase
06/01/2010US7727744 Using transposon insertion to genetically engineer proteins, identify protein domains, change protein functionality, epitope map and prepare antigenic peptides for production of vaccines
06/01/2010US7727742 Nucleic acid molecules encoding fibroblast growth factor-like polypeptides
06/01/2010US7727741 Nucleotide sequences coding glycoengineered peptides with enhance Fc receptor binding affinity and effector function for treatment and prevention of cell proliferative disorders
06/01/2010US7727731 Potent, selective and non toxic c-kit inhibitors
06/01/2010US7727713 Templated molecules and methods for using such molecules
06/01/2010US7727712 Having an immunostimulatory sequence comprising the sequence 5'-C, G-3', wherein an HBV antigen is not administered in conjunction with administration of said nucleotide; for treatment of subject with hepatitis B virus
06/01/2010US7727572 food products such as doughs and dairy products, animal feed, pharmaceuticals, cosmetics, dental care products
06/01/2010US7727536 EG-VEGF nucleic acids and polypeptides and methods of use
06/01/2010US7727535 Protein comprising amino acid sequence with one to 20 amino acid substitutions, deletions or insertions; lower affinity binding to alpha thrombin, lower aggregation, or proteolysis resistance; inflammation, thrombosis, atherosclerosis, angioplasty-related restenosis; cardiovascular disorders
06/01/2010US7727534 Gentically engineered viral particles for use in targeted tumor destruction; Antitumor agents
06/01/2010US7727529 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
06/01/2010US7727522 Simian immunodeficiency retroviral vector for use efficient tool in heterologous gene transfer; improved exogenous gene expression; gene therapy
06/01/2010CA2512040C Designed deimmunized monoclonal antibodies for protection against hiv exposure and treatment of hiv infection
06/01/2010CA2480727C Gene coding for acetolactate synthase
06/01/2010CA2442679C Methods for secretory production of proteins
06/01/2010CA2441952C Plasmodium falciparum ama-1 protein and uses thereof
06/01/2010CA2424700C Genetic immunisation against cervical carcinoma
06/01/2010CA2393476C Dna sequence imparting cytoplasmic male sterility, mitochondrial genome, nuclear genome, mitochondria and plant containing said sequence and process for the preparation of hybrids
06/01/2010CA2370666C A tenascin-c isoform as a marker for neoplasias
06/01/2010CA2369045C Methods for improving sensitivity and specificity of screening assays
06/01/2010CA2358915C Modified hiv env polypeptides
06/01/2010CA2336221C Human neuronal acid-sensitive cationic channels, its cloning and applications
06/01/2010CA2309925C Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype
06/01/2010CA2304376C Dna-construct for the tissue-specific expression of a blood coagulation factor
06/01/2010CA2288600C A method for making multispecific antibodies having heteromultimeric and common components
06/01/2010CA2288373C Human cerberus protein
06/01/2010CA2221495C Methods and uses for apoptin
06/01/2010CA2219961C Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
06/01/2010CA2203933C Nucleotide sequences hybridizing specifically with a genomic nucleic sequence of campylobacter
06/01/2010CA2115839C Hla-restricted hepatitis b virus ctl epitopes
05/2010
05/28/2010CA2686597A1 System and method for the automated extraction of nucleic acids
05/27/2010WO2010060099A2 Wall-associated kinase-like polypeptide mediates nutritional status perception and response
05/27/2010WO2010060096A2 Compositions and methods for increasing cellulose production
05/27/2010WO2010060035A1 Snake factor v and methods of use as a procoagulant
05/27/2010WO2010060030A1 Tlr ligand-nucleic acid nanostructure as a novel immune modulatory agent and method of using the same
05/27/2010WO2010059965A2 Methods and compositions for generating self attenuating genetic circuitry
05/27/2010WO2010059914A2 Nucleic acid quantification products and processes
05/27/2010WO2010059821A1 Anti-unc5b antibodies and methods of use
05/27/2010WO2010059806A2 Generation of induced pluripotent stem cells without the use of viral vectors
05/27/2010WO2010059763A1 Compositions and methods for the assembly of polynucleotides
05/27/2010WO2010059616A2 Biocatalysts and methods for conversion of hemicellulose hydrolsates to biobased products
05/27/2010WO2010059598A1 Methods for producing fish with high lipid content
05/27/2010WO2010059558A2 Plant defense genes and proteins and methods of use
05/27/2010WO2010059539A2 Genetically engineered yeast for the production of biofuels
05/27/2010WO2010059413A2 Polypeptides having amylolytic enhancing activity and polynucleotides encoding same
05/27/2010WO2010059323A2 Sequence amplification with target primers
05/27/2010WO2010059004A2 Chemical inhibitor of p53-snail binding and pharmaceutical composition for treating cancer disease containing same as its active ingredient
05/27/2010WO2010058824A1 Substance for regulating differentiation into mesenchymal cell, and use thereof
05/27/2010WO2010058707A1 Fusion collagenase to which affinity tag is attached, and method for producing same
05/27/2010WO2010058572A1 Methods for diagnosing or treating prostate cancer
05/27/2010WO2010058428A2 Identification of genes related to abiotic stress tolerance in jatropha curcas
05/27/2010WO2010058426A2 Inhibition of vegf-a secretion, angiogenesis and/or neoangiogenesis by sina mediated knockdown of vegf-c and rhoa
05/27/2010WO2010058418A2 Novel synthetic expression vehicle
05/27/2010WO2010058189A1 Oligonucleotides capable of discriminating between nucleic acid sequences that comprise a conserved sequence
05/27/2010WO2010058097A1 Truncated cd20 protein, deltacd20
05/27/2010WO2010058057A1 Laccases having high redox potential obtained through directed evolution
05/27/2010WO2010057650A1 Vector comprising multiple homologous nucleotide sequences
05/27/2010WO2010057620A1 Expression cassettes for seed-enhanced expression in plants
05/27/2010WO2010057614A1 Reprogramming cells toward a pluripotent state
05/27/2010WO2010057501A1 Priming of an immune response
05/27/2010WO2010057427A1 Genetic material processing and manipulation methods
05/27/2010WO2010057330A1 Recombinant peptide molecule for treating saprolegniasis
05/27/2010WO2010057271A1 Polyhydroxyalkanoate production in plant peroxisomes
05/27/2010WO2010057259A1 Protein stability assay using a fluorescent reporter of protein folding
05/27/2010WO2010057246A1 Enzymes and methods for producing omega-3 fatty acids
05/27/2010WO2010041145A3 Il-17-mediated transfection methods
05/27/2010WO2010038145A3 Kit for the optimisation of protein synthesis/secretion
05/27/2010WO2010037130A3 Compositions and methods of generating reprogrammed adipocyte cells and methods of use therefore
05/27/2010WO2010030171A8 Method for diagnostic marker development
05/27/2010WO2010029311A3 Herbicide tolerant plants
05/27/2010WO2010027977A3 Colorimetric bioassay for perchlorate
05/27/2010WO2010025374A3 Manipulation of snf1 protein kinase activity for altered oil content in oleaginous organisms
05/27/2010WO2010025287A9 Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine